255 related articles for article (PubMed ID: 30849525)
1. Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirus.
Hasan M; Azim KF; Begum A; Khan NA; Shammi TS; Imran AS; Chowdhury IM; Urme SRA
Infect Genet Evol; 2019 Jun; 70():140-157. PubMed ID: 30849525
[TBL] [Abstract][Full Text] [Related]
2. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus.
Hasan M; Ghosh PP; Azim KF; Mukta S; Abir RA; Nahar J; Hasan Khan MM
Microb Pathog; 2019 May; 130():19-37. PubMed ID: 30822457
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus).
Azim KF; Hasan M; Hossain MN; Somana SR; Hoque SF; Bappy MNI; Chowdhury AT; Lasker T
Infect Genet Evol; 2019 Oct; 74():103936. PubMed ID: 31233780
[TBL] [Abstract][Full Text] [Related]
4. Contriving a chimeric polyvalent vaccine to prevent infections caused by herpes simplex virus (type-1 and type-2): an exploratory immunoinformatic approach.
Hasan M; Islam S; Chakraborty S; Mustafa AH; Azim KF; Joy ZF; Hossain MN; Foysal SH; Hasan MN
J Biomol Struct Dyn; 2020 Jul; 38(10):2898-2915. PubMed ID: 31328668
[TBL] [Abstract][Full Text] [Related]
5. Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus.
Ullah MA; Sarkar B; Islam SS
Immunobiology; 2020 May; 225(3):151949. PubMed ID: 32444135
[TBL] [Abstract][Full Text] [Related]
6. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
Wang D; Schmaljohn AL; Raja NU; Trubey CM; Juompan LY; Luo M; Deitz SB; Yu H; Woraratanadharm J; Holman DH; Moore KM; Swain BM; Pratt WD; Dong JY
Vaccine; 2006 Apr; 24(15):2975-86. PubMed ID: 16530297
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach.
Hasan M; Azim KF; Imran MAS; Chowdhury IM; Urme SRA; Parvez MSA; Uddin MB; Ahmed SSU
PLoS One; 2020; 15(8):e0237181. PubMed ID: 32813697
[TBL] [Abstract][Full Text] [Related]
8. Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family.
Azim KF; Lasker T; Akter R; Hia MM; Bhuiyan OF; Hasan M; Hossain MN
Heliyon; 2021 May; 7(5):e07022. PubMed ID: 34041391
[TBL] [Abstract][Full Text] [Related]
9. Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever.
Albaqami FF; Altharawi A; Althurwi HN; Alharthy KM; Qasim M; Muhseen ZT; Tahir Ul Qamar M
Biomed Res Int; 2023; 2023():5560605. PubMed ID: 37101690
[TBL] [Abstract][Full Text] [Related]
10. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
[TBL] [Abstract][Full Text] [Related]
12. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus.
Khan MSA; Nain Z; Syed SB; Abdulla F; Moni MA; Sheam MM; Karim MM; Adhikari UK
Mol Cell Probes; 2021 Feb; 55():101693. PubMed ID: 33388416
[TBL] [Abstract][Full Text] [Related]
13. Mining of Marburg Virus Proteome for Designing an Epitope-Based Vaccine.
Soltan MA; Abdulsahib WK; Amer M; Refaat AM; Bagalagel AA; Diri RM; Albogami S; Fayad E; Eid RA; Sharaf SMA; Elhady SS; Darwish KM; Eldeen MA
Front Immunol; 2022; 13():907481. PubMed ID: 35911751
[TBL] [Abstract][Full Text] [Related]
14. Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection.
Kumar Pandey R; Ojha R; Mishra A; Kumar Prajapati V
J Cell Biochem; 2018 Sep; 119(9):7631-7642. PubMed ID: 29900580
[TBL] [Abstract][Full Text] [Related]
15. Designing a novel and combinatorial multi-antigenic epitope-based vaccine "MarVax" against Marburg virus-a reverse vaccinology and immunoinformatics approach.
Debroy B; Chowdhury S; Pal K
J Genet Eng Biotechnol; 2023 Nov; 21(1):143. PubMed ID: 38012426
[TBL] [Abstract][Full Text] [Related]
16. Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine.
Akhand MRN; Azim KF; Hoque SF; Moli MA; Joy BD; Akter H; Afif IK; Ahmed N; Hasan M
Infect Genet Evol; 2020 Nov; 85():104517. PubMed ID: 32882432
[TBL] [Abstract][Full Text] [Related]
17. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
Hevey M; Negley D; Pushko P; Smith J; Schmaljohn A
Virology; 1998 Nov; 251(1):28-37. PubMed ID: 9813200
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions.
Bozhanova NG; Sangha AK; Sevy AM; Gilchuk P; Huang K; Nargi RS; Reidy JX; Trivette A; Carnahan RH; Bukreyev A; Crowe JE; Meiler J
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31142-31148. PubMed ID: 33229516
[TBL] [Abstract][Full Text] [Related]
19. Computational vaccinology guided design of multi-epitopes subunit vaccine designing against Hantaan virus and its validation through immune simulations.
Ghafoor D; Kousar A; Ahmed W; Khan S; Ullah Z; Ullah N; Khan S; Ahmed S; Khan Z; Riaz R
Infect Genet Evol; 2021 Sep; 93():104950. PubMed ID: 34089911
[TBL] [Abstract][Full Text] [Related]
20. Immunoinformatic screening of Marburgvirus epitopes and computational investigations of epitope-allele complexes.
Baral P; Pavadai E; Zhou Z; Xu Y; Tison CK; Pokhrel R; Gerstman BS; Chapagain PP
Int Immunopharmacol; 2022 Oct; 111():109109. PubMed ID: 35926269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
